Investors should remain flexible and seek income from a variety of sources amid an outlook of higher inflation and tighter monetary policy.
Andy Acker, global life sciences portfolio manager, explores the unprecedented number of medical breakthroughs occurring in healthcare and what it means for the sector.
Despite the calamities of Covid-19, some companies in Japan still grew strongly thanks to the acceleration of a number of trends.
Nature is critical for human existence, but it is under increasing stress – because of us.
Your Questions Answered: A quarterly Q&A series featuring the top 10 questions that clients and prospective clients ask our investment teams.
Capture on China’s rebound and check risks ahead, Schroders’ Jack Lee says.
Aviva Investors’ Francois de Bruin reflects on a momentous period for economies and markets.
In today’s lower-for-longer rates environment, where bonds no longer provide the reliability in returns and safety that investors want, yield with controlled risk is highly sought after. The US housing sector can fill the gap, say senior executives at Walton.
We explain why credit investors cannot just rely on rates and diversification for protection and discuss the tools that support capital preservation during market sell-offs.
Disease treatment is changing rapidly, leading to new therapies and better long-term results for patients — and creating investment opportunities, according to Andy Acker, portfolio manager, Janus Henderson Global Life Sciences and Dan Lyons, research analyst.